Transcept Stock Gaps Down On Today's Open (TSPT)

NEW YORK ( TheStreet) -- Shares of Transcept Pharmaceuticals (Nasdaq: TSPT) were gapping down Thursday morning with an open price 12.7% lower than Wednesday's closing price. The stock closed at $11 Wednesday and opened today's trading at $9.60.

The average volume for Transcept has been 151,100 shares per day over the past 30 days. Transcept has a market cap of $152.6 million and is part of the health care sector and drugs industry. Shares are up 40.5% year to date as of the close of trading on Wednesday.

Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of proprietary products that address therapeutic needs in the field of neuroscience.

TheStreet Ratings rates Transcept as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we find that the growth in the company's earnings per share has not been good. You can view the full Transcept Ratings Report.

Get more investment ideas from our investment research center.

null

More from Markets

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%